Jan 30, 20222 min"First-In-Man Clinical Trial – Zygosid-50 for treating T2D" - summary of results (partial)The primary efficacy objective of the study was to demonstrate that treatment with Zygosid-50 yields a significant reduction in the...
May 24, 20211 minOur CLINICAL TRIAL is now Recruiting Type 2 Diabetes PatientsConcenter Biopharma, together with the SHEBA Medical Center in Israel recently began recruiting patients for the clinical trial using the...
May 2, 20211 minWINNERS OF THE 2021 BIOTECHNOLOGY AWARDS Concenter BioPharma chosen as WINNERS OF THE 2021 BIOTECHNOLOGY AWARDS